These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29429401)
1. Evaluation of serum neutrophil gelatinase-associated lipocalin as a novel biomarker of cardiorenal syndrome in dogs. Jung HB; Kang MH; Park HM J Vet Diagn Invest; 2018 May; 30(3):386-391. PubMed ID: 29429401 [TBL] [Abstract][Full Text] [Related]
2. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome. Ronco C; Cruz D; Noland BW Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil Gelatinase-Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease. Wang IC; Hsu WL; Wu PH; Yin HY; Tsai HJ; Lee YJ J Vet Intern Med; 2017 Jan; 31(1):102-108. PubMed ID: 28019047 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure. Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992 [TBL] [Abstract][Full Text] [Related]
6. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1. Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma neutrophil gelatinase-associated lipocalin in patients with heart failure. Villacorta H; Santos RA; Marroig MA; Pereira GP; Xavier AR; Kanaan S Rev Port Cardiol; 2015; 34(7-8):473-8. PubMed ID: 26162288 [TBL] [Abstract][Full Text] [Related]
8. Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure. Damman K; Valente MAE; van Veldhuisen DJ; Cleland JGF; O'Connor CM; Metra M; Ponikowski P; Cotter G; Davison B; Givertz MM; Bloomfield DM; Hillege HL; Voors AA Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698481 [TBL] [Abstract][Full Text] [Related]
13. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin. Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724 [TBL] [Abstract][Full Text] [Related]
14. Urinary neutrophil gelatinase-associated lipocalin as early biomarker for renal disease in dogs with leishmaniosis. Ruiz P; Durán Á; Gil M; Sevidane I; Cristóbal JI; Nicolás P; Duque FJ; Zaragoza C; García AB; Macías-García B; Barrera R Vet Parasitol; 2024 Oct; 331():110251. PubMed ID: 39002284 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil gelatinase-associated lipocalin does not predict acute kidney injury in heart failure. Ferrari F; Scalzotto E; Esposito P; Samoni S; Mistrorigo F; Rizo Topete LM; De Cal M; Virzì GM; Corradi V; Torregrossa R; Valle R; Bianzina S; Aspromonte N; Floris M; Fontanelli A; Brendolan A; Ronco C World J Clin Cases; 2020 May; 8(9):1600-1607. PubMed ID: 32432138 [TBL] [Abstract][Full Text] [Related]
16. Validation of an ELISA for detection of neutrophil gelatinase-associated lipocalin (NGAL) in equine serum. Jacobsen S; Berg LC; Tvermose E; Laurberg MB; van Galen G Vet Clin Pathol; 2018 Dec; 47(4):603-607. PubMed ID: 30403420 [TBL] [Abstract][Full Text] [Related]
17. Cardiorenal Syndrome: Diagnosis and Management. Orvalho JS; Cowgill LD Vet Clin North Am Small Anim Pract; 2017 Sep; 47(5):1083-1102. PubMed ID: 28669432 [TBL] [Abstract][Full Text] [Related]
18. Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome. Du X; Ma Z; Li L; Zhong X J Cardiovasc Pharmacol; 2021 Sep; 78(5):e675-e680. PubMed ID: 34738551 [TBL] [Abstract][Full Text] [Related]
19. Circulating miRNA-21 as a diagnostic biomarker in elderly patients with type 2 cardiorenal syndrome. Wang Y; Liang Y; Zhao W; Fu G; Li Q; Min X; Guo Y Sci Rep; 2020 Mar; 10(1):4894. PubMed ID: 32184430 [TBL] [Abstract][Full Text] [Related]
20. Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1. Virzì GM; Breglia A; Ankawi G; Bolin C; de Cal M; Cianci V; Vescovo G; Ronco C Cardiorenal Med; 2019; 9(5):308-315. PubMed ID: 31238313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]